{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-082005","form_type":"8-K","ticker":"HCWB","cik":"0001828673","company_name":"HCW Biologics Inc.","filed_at":"2025-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.985330+00:00","generated_at":"2026-05-19T22:37:32.073040+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"HCW Biologics resolves Nasdaq compliance, closes $5M offering, earns $7M license fee from WY Biotech","bullets":["Nasdaq confirms compliance with bid price and MVPHS rules; company believes full compliance for Capital Market listing.","Closed $5M follow-on offering (671,140 units at $7.45/unit) and reduced existing warrant exercise price to $7.45.","WY Biotech license fully binding; HCW Biologics earns $7M upfront fee recognized in Q2 2025.","Converted $6.6M secured notes into common stock, warrants, and Wugen shares; reduced debt and improved equity."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-082005","json":"https://secwatch.observer/filing/0000950170-25-082005.json","markdown":"https://secwatch.observer/filing/0000950170-25-082005.md","text":"https://secwatch.observer/filing/0000950170-25-082005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025082005/0000950170-25-082005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025082005/hcwb-20250605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T22:37:32.073040+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}